Assessing incidence and economic burden of genital warts with data from a US commercially insured population

Current Medical Research and Opinion

Volumn 25, Issue 10, 2009, Pages 2343-2351

  Hoy, Tracey ^a   Singhal, Puneet K ^b   Willey, Vincent J ^c   Insinga, Ralph P ^b  

^a HEALTHCORE INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Costs; Epidemiology; Genital warts; Incidence; Managed care

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INCIDENCE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; NEWBORN; POPULATION; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONDYLOMATA ACUMINATA; COST OF ILLNESS; EPISODE OF CARE; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 70349314677     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903136378     Document Type: Article

References (44)

1. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995;33:2058-2063
2. Cates Jr W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999;26:S2-7
3. Fleischer Jr AB, Parrish CA, Glenn R, et al. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis 2001;28:643-647 (Pubitemid 33055108)
4. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-163 (Pubitemid 18262843)
5. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003;36:1397-1403
6. Weaver BA. Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc 2006;106:S2-8
7. Centers for Disease Control STD Surveillance 2005. Table 42. Selected STDs and complications - initial visits to physicians' offices. National Disease and Therapeutic Index: United States, 1966-2005. Available at: http://www.cdc.gov/std/stats/tables/table42.htm. [Last accessed: October 17, 2007]
8. Wiley D, Masongsong E. Human papillomavirus: the burden of infection. Obstet Gynecol Surv 2006;61:S3-14
9. Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002;35:S210-24 (Pubitemid 35178333)
10. Beutner KR, Wiley DJ, Douglas JM, et al. Genital warts and their treatment. Clin Infect Dis 1999;28(Suppl 1):S37-56
11. Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 2006;12:5. Available at: http://dermatology.cdlib.org/123/reviews/warts/scheinfeld.html [Last accessed: October 18, 2007]
12. Brown DR, Schroeder JM, Bryan JT, et al. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:3316-3322
13. Wilson J. Treatment of genital warts - what's the evidence? Int J STD AIDS 2002;13:216-220
14. Chuang TY, Perry HO, Kurland LT, et al. Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol 1984;120:469-475
15. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-578 (Pubitemid 28474812)
16. Clarke P, Ebel C, Catotti DN, et al. The psychosocial impact of human papillomavirus infection: implications for healthcare providers. Int J STD AIDS 1996;7:197-200 (Pubitemid 26191688)
17. Shinn E, Basen-Engquist K, Le T, et al. Distress after an abnormal Pap smear result: scale development and psychometric validation. Prev Med 2004;39:404-412 (Pubitemid 38834031)
18. McCaffery K, Waller J, Forrest S, et al. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004;111:1437-1443 (Pubitemid 39665037)
19. Harper DM. Why am I scared of HPV? CA Cancer J Clin 2004;54:245-247
20. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007;110:87-95 (Pubitemid 47015705)
21. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005;23:1107-1122
22. Health Protection Agency. Mapping the issues. HIV and Other Sexually Transmitted Infections in the United Kingdom, 2005 Available at: www.hpa.org.uk/hpa/publications/hiv-sti-2005/warts.htm. [Last accessed: October 17, 2007]
23. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(Suppl 1):S1-15
24. Wilson T. Consumer price index, 2004. Monthly Labor Review 2005(April):1-8 Available at: http://www.bls.gov/opub/mlr/2005/04/art1full.pdf [Last accessed: October 12, 2007]
25. Marra F, Ogilvie G, Colley L, et al. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect 2009;85:111-115
26. Monsonégo J, Breugelmans JG, Bouée S, et al. Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynecologie, Obstetrique & Fertilite 2007;35:107-113 (Pubitemid 46304309)
27. Hillemanns P, Breugelmans JG, Gieseking F, et al. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis 2008;8:76 (Pubitemid 351917429)
28. Kahn JA, Rosenthal SL, Succop PA, et al. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002;109:E5
29. Aral SO, Hughes JP, Stoner B, et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health 1999;89:825-833 (Pubitemid 29282699)
30. Tracking the hidden epidemics: Trends in STDs in the United States 2000. Available at: http://www.cdc.gov/std/Trends2000/Trends2000.pdf. [Last accessed: October 18, 2007]
31. Health Protection Agency. Epidemiological data 2005: Genital warts. Available at: http://www.hpa.org.uk/infections/topics-az/hiv-and-sti/sti-warts/ epidemiology.htmWidth1WidthB3Width3Width8856. [Last accessed: October 16, 2007]
32. Weinstock H, Berman S, Cates Jr W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10
33. Myers ER, McCrory DC, Nanda K, et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-1171 (Pubitemid 30451948)
34. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health 2000;25:67-78 (Pubitemid 30112206)
35. Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health 2005;37:S3-S9
36. Tao G, Kassler WJ, Rein DB. Medical care expenditures for genital herpes in the United States. Sex Transm Dis 2000;27:32-38 (Pubitemid 30058902)
37. Celum CL, Bolan G, Krone M, et al. Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis 1997;24:599-605
38. Frost JJ. Public or private providers? U.S. women's use of reproductive health services. Fam Plann Perspect 2001;33:4-12 (Pubitemid 32163632)
39. Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999;31:10-15
40. Civic D, Scholes D, Grothaus L, et al. Adolescent HMO enrollees' utilization of out-of-plan services. J Adolesc Health 2001;28:491-496 (Pubitemid 32509591)
41. Lezzoni LI, Foley SM, Daley J, et al. Comorbidities, complications, and coding bias: does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA 1992;267:2197-2203
42. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994;32:81-90
43. Sambamoorthi U, Shea D, Crystal S. Total and out-of-pocket expenditures for prescription drugs among older persons. Gerontologist 2003;43:345-359 (Pubitemid 36718409)
44. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? Sex Transm Dis 2002;29:725-735